India keeps diabetes drug prices low through generic manufacturing
Published · Updated
AI-generated summary of the coverage listed below: A study by diabetologists links India’s low medication prices to its status as a major pharmaceutical exporter. Legislation that blocks patent evergreening and allows generic drug production supports the affordability of expensive diabetes medicines.
Covered by 1 outlet across the spectrum: 100% left, 0% center, 0% right.
Who is covering this story
- Left-leaning (1): The Hindu
Sources
- Study attempts to find out how India made expensive diabetes medicines affordable — The Hindu (left-leaning)